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NRF2 is the master transcriptional regulator of oxidative and xenobiotic stress responses. NRF2 has important roles in
carcinogenesis, inflammation, and neurodegenerative diseases. We developed an online resource, NRF2-ome, to provide an
integrated and systems-level database for NRF2. The database contains manually curated and predicted interactions of NRF2 as
well as data from external interaction databases. We integrated NRF2 interactome with NRF2 target genes, NRF2 regulating TFs,
and miRNAs. We connected NRF2-ome to signaling pathways to allow mapping upstream NRF2 regulatory components that
could directly or indirectly influence NRF2 activity totaling 35,967 protein-protein and signaling interactions. The user-friendly
website allows researchers without computational background to search, browse, and download the database. The database can
be downloaded in SQL, CSV, BioPAX, SBML, PSI-MI, and in a Cytoscape CYS file formats. We illustrated the applicability of the
website by suggesting a posttranscriptional negative feedback of NRF2 by MAFG protein and raised the possibility of a connection
between NRF2 and the JAK/STAT pathway through STAT1 and STAT3. NRF2-ome can also be used as an evaluation tool to help
researchers and drug developers to understand the hidden regulatory mechanisms in the complex network of NRF2.
1. Introduction
NRF2 (NF-E2-related factor 2, NFE2L2) transcription fac-
tor is the master controller of oxidative and xenobiotic
stress responses [1]. Function of NRF2 influences oxidative
stress-related physiologic and pathologic processes such as
carcinogenesis, inflammation, and neurodegeneration [2].
Upon oxidative stress, NRF2 enters the nucleus and activates
the expression of antioxidant-responsive-element- (ARE-)
dependent genes to maintain cellular redox homeostasis [3].
Activation of NRF2 is a well-known response to environ-
mental and endogenous stresses. NRF2 activation is mainly
regulated by signaling processes and pathways (e.g., MAPKs
and PI3K) that target NRF2 or its cytoplasmic repressor,
KEAP1 [3, 4].
While there are nearly 3000 articles for the keyword
“NRF2” in PubMed (as of January 2013), major network
resources (BioGRID, MINT, STRING, HPRD and InnateDB)
contain only a few dozen NRF2 interactors. Prompted by the
lack of a systems-level NRF2-related resource, we recently
collected the literature information on NRF2 interacting
proteins and regulated genes, as well as predicted novel NRF2
interactors and regulators [5]. We also imported NRF2 reg-
ulating transcription factors (TFs) and miRNAs from major
network resources. The NRF2 interactome and regulome
datasets allowed us to examine fine-tuning autoregulatory
loops of NRF2 and to identify multifunctional proteins
interacting with NRF2 [5]. However, the former dataset [5] is
stored in more than 16 separate datasheet tables, containing
minimal information on the proteins (only the short name of
a protein with one UniProt ID) and no links to web resources
or other datasheets. This format makes further analysis diffi-
cult for several reasons. (1) Search in the datasheets requires
the canonical short name of a protein though each protein has
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several synonyms. (2) The separate datasheets neither allow
any global search for a given protein, nor provide a uniform
data collection about an NRF2 interactor. (3) Only experts
with computational background could visualize and perform
network analysis with the datasets. Importantly, the formerly
published datasheets [5] contain mostly NRF2-centric (i.e.,
star-like) interactions and regulatory information and lack
important cross-regulatory connections betweenNRF2 inter-
actors and other TFs or signaling proteins that are indirectly
connected to NRF2.
Here, we report the development of a user-friendly web
resource to analyze systems-level data on NRF2, which we
hope will provide a help for researchers working with NRF2
or NRF2-related processes. Going beyond the creation of a
database based on the datasheets on NRF2 interactome and
regulome [5], we extended this database with further protein-
protein and regulatory information. We also included sig-
naling pathway data from SignaLink 2, a signaling net-
work resource we previously developed [6, 7]. This process
extended the number of protein-protein interactions from
the previously published [5] 311 to 13,053 and the regulatory
connections from 8,833 to 22,095. Finally, we created a
novel website (http://nrf2.elte.hu/) to provide an easy-to-use
graphical interface allowing users to browse or download the
NRF2-ome resource.
2. Materials and Methods
2.1. Compilation of NRF2-ome Resource. The NRF2-ome
contains a manually curated core interactome, which was
extended with further protein-protein interactions (PPIs) as
well as with transcriptional and posttranscriptional regu-
latory components and interactions. In the following, we
list the compilation process of the NRF2-ome resource
(Figure 1).
The starting point of NRF2-ome was a set of 112 interac-
tions between 84NRF2 interactor proteins that we previously
developed by manual curation of the literature [5]. All
these interactions were found in human cells and further
information about the interactions (e.g., direction, and the
literature reference) were already listed. To extend this infor-
mation, we used experimentally verified interactions from
PPI databases and in silicopredictions to create the network of
first neighbors ofNRF2.We used the following PPI databases:
InnateDB [8], HPRD [9], and BioGRID [10]. InnateDB and
HPRD contain mostly curated interaction data from small-
and medium-scale studies, while BioGRID also contains
high-throughput studies. For additional enrichment of the
NRF2-ome resource, we predicted novel interactions based
on protein structure data. We used domain composition
data from PFAM and domain-domain interactions data
from DOMINE [11, 12] to predict undirected PPIs based
on domain-domain interactions. To predict directed PPIs,
we used domain-motif-interactions, retrieved from the ELM
Server [13]. We used only those domain-motif-based PPIs
for which ELM’s Structure Filter cut-off value was above the
default.
Next, we integrated regulatory information for NRF2 and
for the already included first neighbors of NRF2. To identify
TFs that regulateNRF2 or its first neighbors, we importedTF-
target gene interactions from the following databases: ABS,
ENCODE, HTRIdb, JASPAR, and ORegAnno [14–18]. To list
the target genes of NRF2, we used the previously curated data
of the literature [5], as well as integrated data from InnateDB
[8], two ChIP-Seq profiling studies [19, 20], and JASPAR-
based predictions [8]. If an interaction was found in multiple
resources or methods, then we listed all versions, offering a
comprehensive view. We also integrated posttranscriptional
regulatory interactions (i.e., miRNAs that can regulate NRF2
or its first neighbors) by manual curation and frommiRBase,
TarBase, Miranda, TargetScan, andmiRecords resources [21–
25]. To list those TFs that can regulate NRF2-regulating
miRNAs, we used data on the transcriptional regulation of
miRNAs from ENCODE, PutMir, and TransMir resources
[18, 26, 27].
Finally, we used SignaLink 2, a signaling network resource
we recently developed [6, 7], to connect all of the already
included proteins to signaling pathways. SignaLink 2 contains
7 major signaling pathways: RTK (receptor tyrosine kinase),
TGF-𝛽 (transforming growth factor beta), WNT/Wingless,
Hedgehog, JAK/STAT, Notch, and NHR (nuclear hormone
receptor) [6]. Integration of signaling pathways to NRF2-
ome allows the mapping upstream components of NRF2 and
other TFs, which regulate NRF2 or its first neighbors. As a
final step, we used BioGRID [10] and HPRD [9] resources
again to include further PPIs known between all the inserted
components (e.g., PPIs between TFs, or between signaling
pathway components and NRF2 interactors).
2.2. Database Implementation and Structure. NRF2-ome
stores data in a MySQL database, which is connected to the
webpage by an interface written in PHP. On the client side,
the webpage uses jQuery to offer a high interactivity. It loads
data asynchronously by small http requests, making possible
to efficiently browse through hundreds of interactions. Data
can be exported and downloaded in various formats: CSV,
BioPAX, PSI-MI TAB, PSI-MI XML, SBML, and Cytoscape’s
CYS format. The download page offers several options to
customize the network to be the downloaded; user can
select desired interaction types (e.g., PPIs and transcriptional
regulation) and filter the interactions by sources. There is
an option to separate experimentally verified and predicted
interactions. The customized network files are generated
after the selection, by an export module running in the
background, implemented in Python. This process can take
fewminutes.Then, for each download, the database generates
aURL, where users can access the data for 14 days. Optionally,
users can provide their e-mail addresses to which files smaller
than 10MB will be e-mailed. The whole dataset is also
available as a standard SQL dump, so that any complex query
or modification can be applied using SQL statements.
The core of NRF2-ome database is the interaction
table. In the interaction table source and target fields are
integers pointing to the primary keys of protein or mirna
tables. The layer field denotes the type of the interaction, and
its value determines whether the source or the target refer to
a protein or miRNA. The meanings of the values in the layer
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Figure 1: The workflow of the compilation process of NRF2-ome. NRF2-ome is based on the manually curated collection of first neighbor
interactors and target genes of NRF2 [5]. The manual curation was extended and complemented with the integration of external databases
and predictions on further NRF2 interactors and target genes.The network of TF andmiRNA regulators was built upon this interactome and
regulome. At this phase, the TFs of miRNAs were also included. Finally, we integrated upstream connections to manually curated signaling
pathway from the SignaLink 2 resource.
field are the following: 1: PPIs in the interactome of NRF2;
4: TF-target interactions; 5: miRNA-mRNA interactions; 6:
PPIs in the signaling pathways, imported from SignaLink 2;
7: TF-miRNA connections (values 2 and 3 are not functional
in the current version of the database). Each interaction has
three main attributes: is directed (0: undirected; 1: directed;
2: direction is predicted), is direct (0: indirect; 1: direct), and
is stimulation (0: unknown; 1: stimulation, -1: inhibition). In
addition, interactions have one or more sources. Sources are
listed in the source table, and the interaction source
table contains their assignment to the interaction table.
Manually curated interactions have the literature references,
contained by the interaction reference table. In the
interaction reference table, articles are identified by
their Pubmed IDs. Most of the interactions have con-
fidence scores. These are stored as float values in the
interaction weight table, while the different types of
scores are listed in weight table. Components of the NRF2-
ome are listed in the protein and mirna tables. The
protein table contains the uniprot name field, which is
unique, and it contains the UniProt accession number of
proteins. All records imported from other databases as
well as protein names from articles have been mapped to
their primary UniProtKB ID. Proteins may have signaling
topological properties and pathway assignments, available in
protein topology and protein pathway tables. In the
mirna table, we used miRBase AC and miRNA name to
identify miRNAs. Figure 2 shows the scheme of the SQL
database.
3. Results and Discussion
3.1. The NRF2-ome Database. The NRF2-ome database con-
tains interactors and regulators of NRF2, their interactions
to NRF2, and physical as well as regulatory interactions
between them. Altogether, the NRF2-ome database contains
7,777 proteins and 35,967 interactions (Figure 3). From the
7,777 proteins, 227 are directly interacting with NRF2, 45 are
TFs directly regulating NRF2, while 165 TFs are regulating
miRNAs capable to downregulate NRF2. 7,252 proteins in
the NRF2-ome database are encoded by genes regulated
by NRF2. Interestingly, there are only 108 proteins that
are both interactors and target genes of NRF2. We also
integrated signaling pathway data and found that from the
7,777 proteins, 591 are involved in signaling. As a more
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Figure 2: The SQL database scheme of the NRF2-ome resource. See the main text for details.
indirect connection, we found 51 signaling pathway proteins
interactingwithNRF2, 163 pathway proteins binding toNRF2
interactors and 8 pathway proteins affecting TFs regulating
NRF2. We note that the NRF2-ome database also contains
pathway connections through second neighbor interactors.
There are four types of interactions in the NRF2-ome
database: (1) protein-protein interactions; (2) TF-target gene
regulatory connections; (3) miRNA-mRNA regulatory inter-
actions; (4) TF-miRNA regulatory connections. Figure 3(b)
shows the number of interactions by types in the NRF2-
ome database. For all four categories, NRF2-ome contains
both experimentally verified and predicted connections. As
NRF2-ome distinguishes between these two evidence types
and also interactions are stored with their original sources,
users can examine interactions separately according to their
requirements.
3.2. The NRF2-ome Website. We developed a user-friendly
web interface for NRF2-ome that can be accessed at
http://nrf2.elte.hu/. The aim of the website is twofold. (1) It
gives an interactive opportunity to browse the NRF2-ome
database and use hyperlinks to other web resources and
Pubmed abstracts. (2) It provides an easy-to-use download
interface, where users without computational background
can select data from the content of the NRF2-ome database.
The search field available on themain page autocompletes the
queried terms to facilitate users’ search. The search engine
of NRF2-ome understands many database IDs, accession
numbers, and protein names based on the mapping table
of UniProt [28]. If the search term is ambiguous, users can
manually select the needed item from a list.
If the search is successful, a datasheet of the selected
protein or miRNA will be shown (Figures 4(a)–4(d)). The
header of the protein datasheet shows the full name, gene
name, Ensembl protein ID, andUniProtKBACof the protein.
Below the header, an interactive interaction list is shown
to present the first neighbor interactors of the protein. All
details of an interaction can be examined here, including the
interaction properties (direct/indirect, directed/undirected,
stimulatory/inhibitory, and predicted/experimentally veri-
fied) and the Pubmed links to the external source fromwhere
we integrated the given interaction, and Pubmed links to
the original paper used as a reference. At the bottom of the
page, we present a “Pathway connections” section.Here, users
can examine connections of the given protein and members
of a signaling pathway interactively selected by the user.
We distinguish between upstream and downstream pathway
interactors (i.e., interactors affecting the given protein or
interactors affected by the given protein, resp.).
On the right side of the protein datasheet page, an
interactive network image is presented, using the Cytoscape
Web embedded flash application [29]. Clicking on the nodes
or edges brings the user to the datasheet page of the selected
protein, miRNA, or interaction. The network view can be
enlarged to full screen mode. By default, only manually
curated and integrated PPIs are shown. Further interactions
can be turned on by the user; however, in case of too many
nodes and edges, the limitations of the flash application
may make the visual experience uncomfortable. In this case,
the webpage gives a warning message before visualizing the
network and recommends the possibility to download a
custom network using the download option of the webpage
and visualize the network offline.
In case of the NRF2 protein, the website provides a
different view because of the high number of interactions
(Figure 4(e)). At the datasheet page of NRF2, the interaction
types and the network image are shown separately, and the
interaction lists are loaded only in small portions to optimize
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Figure 3: Number of components and interactors in the NRF2-ome database. For each category, darker color indicates the improvement of
the dataset compared to the dataset of our earlier publication [5] shown with light color. (a) The number of components (proteins, target
genes, TFs, miRNAs, and miRNA regulating TFs) in the NRF2-ome database. (b) The number and type of interactions in the NRF2-ome
database. Note the small portion of protein-protein interactions (311) and miRNA-mRNA interactions (64) in the earlier publication [5].This
improvement transforms the originally NRF2-centric (i.e., star-like) dataset into a densely connected network resource. We also note that the
earlier publication [5] contained 7,469 target gene IDs, while NRF2-ome contains 7,252 IDs because since then, some of the IDs have been
deleted or merged in the Uniprot resource. Thus, there is a slight decrease in the number of target genes in NRF2-ome, but this decrease is
coupled with more reliable IDs.
the interactive visual experience. Only in the datasheet page
of NRF2 we list regulatory loops. Regulatory loops contain
two or three nodes that form positive or negative feedbacks
to regulate NRF2. The shorter type of these loops consists
a protein interacting with NRF2, or a TF of NRF2, which
is regulated reciprocally by NRF2 at the transcriptional
level. NRF2-ome contains 24 and 12 such proteins and TFs,
respectively. A more loose type of regulatory loops involves
miRNAs that repress the translation of NRF2 and a TF
regulating the transcription of that miRNA and regulated by
NRF2. In NRF2-ome there are 385 such regulatory loops,
involving 61 miRNAs and 82 TFs.
The download option is accessible under the “download”
menu of the webpage. The user interface offers an easy
way to select the desired parts of the database. The entire
database is available as a MySQL dump file. Alternatively,
for less-experienced users, we developed a BioMART-like
customizable download page, where users can easily select
interaction types and file format of the download. A general
switch is also available to exclude all predicted interactions.
The customized subnetworks can be downloaded in various
formats: CSV, BioPAX, SBML, PSI-MI tab or PSI-MI XML,
and in a Cytoscape CYS file.
3.3. Applications of the NRF2-ome Website. We present three
examples to illustrate the applicability of the NRF2-ome web-
site.We show how regulatory loops and pathway connections
can point out important novel information about NRF2.
Both approaches require the integrated transcriptional and
signaling data present in NRF2-ome.
To illustrate the functionality of NRF2 regulatory loops,
we investigated the list of miRNA-containing regulatory
loops. These loops are formed by NRF2, a target gene of
NRF2 that functions as a TF, which regulates a miRNA
capable to downregulate the translation of NRF2. First, we
selected only those loops, where the effect of the miRNA
was experimentally verified. By this, we narrowed the list of
miRNAs from 63 to four miRNAs (miR-27a, miR-28, miR-
93, and miR-144). These four miRNAs form 20 identical
loops with 14 different TFs. We selected the MAFG tran-
scription factor as an example because it was predicted to
regulate the expression of two from the four miRNAs (miR-
93 and miR-144) [26], and there is experimental evidence
that NRF2 positively regulates the expression of MAFG [19]
(Figure 4(e)). MAFG and NRF2 proteins form heterodimers
to promote gene expression of ARE-dependent genes [3].
However, MAFG homodimers and heterodimers with other
smallMAF proteins can repressNRF2 transcriptional activity
by competing with NRF2 at ARE binding sites [30, 31]. Based
on the two regulatory loops involving MAFG and miR-93
or miR-144, here, we suggest an indirect, posttranscriptional
negative feedback, where MAFG could downregulate the
expression of NRF2.
As we integrated signaling pathway data to NRF2-ome,
users can examine the pathway annotations and signaling
connections of known and predictedNRF2 interactors or reg-
ulators. For this analysis, we selected the JAK/STAT pathway
as it has high functional overlap with NRF2. To predict and
explain pathway connection between the JAK/STAT pathway
andNRF2,we selected and examined two JAK/STATpathway
members: STAT1, a predicted TF of NRF2, and STAT3, a
potential interactor of NRF2.
STAT1 is activated in response to interferons (IFN alpha,
beta, and gamma) upon viral infection and inflammation
[32]. As NRF2 has been found be induced by viral infection
and IFN gamma [33, 34], and NRF2 deficient (−/−) mice
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(e)
Figure 4: Combined snapshots of the NRF2-ome web resource. (a)–(d)The protein datasheet page of KEAP1. (a)The header contains the full
name, gene name, UniProt ID, and Ensembl ENSP ID of KEAP1. (b)The interaction list of KEAP1 shows the interactions by types and also the
“Pathway connections” section, which shows one- or two-step-long connections to signaling pathwaymember proteins. Detailed information
on the interactions can be accessed by clicking on the triangles appearing below each interaction. (c) The slide-down box contains sources,
references, and confidence scores of the interactions. (d) The protein datasheet page also contains an interactive visualization of the network
of KEAP1. (e) NRF2 has a special datasheet page at the website, which makes interaction browsing easier for the users. On the bottom of
NRF2 datasheet, page users can choose the interaction types to be shown as well as the regulatory loops involving NRF2. Here, all arrows
symbolizing interactions are clickables, to get the same information about the interaction as on the protein datasheet. We show the details of
the regulatory loop involving MAFG and mir-144 as an example.
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had more severe injuries upon viral exposure [35], we may
hypothesize that STAT1 as a TF can be an important regulator
in the antiviral and anti-inflammatory role of NRF2. Further
experimental validation should determine the role of STAT1
in the expression of NRF2 upon viral infection.
Another member of the JAK/STAT pathway, STAT3
was predicted to interact with NRF2 based on domain-
motif interactions. Though we found no publication that
could validate STAT3-NRF2 interaction, we found several
pieces of indirect, functional evidence, which support this
interaction. Both STAT3 and NRF2 have anti-inflammatory
and antiapoptotic functions upon ethanol exposure [36, 37].
In liver cells, ethanol-induced inflammation and apoptosis
are repressed by globular adiponectin that increases the
production of heme-oxygenase 1 (HO-1) through NRF2 and
the IL-10/STAT3 pathway [38, 39]. As HO-1 can also be
induced in an NRF2-independent way [38], future experi-
ments will be needed to clarify the role of IL-10 and STAT3 in
NRF2-dependent HO-1 induction. In addition, experimental
approaches could validate that IL-10 indeed influences the
activation of NRF2. It is intriguing to speculate that STAT3
and NRF2 may cooperate to serve as anti-inflammatory and
antiapoptotic TFs upon ethanol exposure.
3.4. Discussion. In this work, we significantly extended
our previously developed NRF2 interactome and regulome
dataset [5] and developed it to an easy-to-use systems-level
resource.The current database provides 214manually curated
and predictedNRF2 interactors as well as includes interactors
and regulators from several external resources covering
nearly four times more information than its preliminary
version published earlier [5]. The integrated and unified
database structure allows the users to search data from differ-
ent sources in a single resource.Thus, it does not require prior
bioinformatics knowledge on the prediction tools and on the
structures of the different databases. NRF2-ome also serves
as an integrated resource, where protein interaction and
regulatory and signaling data can be analyzed simultaneously.
The included manual curation was performed in early 2012,
and it will be updated regularly (in each 2 to 3 years). In
addition, as data in the integrated external resources will
probably be extended in the future, we designed the database
building scripts that the database can be easily updated from
the same resources. We plan to update data from external
resources every year.
The NRF2-ome website that we developed to serve
as a graphical interface to the NRF2-ome database
(http://nrf2.elte.hu/) provides a user-friendly environment
to interactively search, browse, or download the database.
The UniProt-based, automatic mapping function of the
search module allows users to search with different names or
database IDs of a protein. On the website, network data on
proteins directly or indirectly related to NRF2 can be easily
accessed. Hyperlinks to further resources and literature
references facilitate the interactive and fast exploration of
protein functions. As a unique feature, we show signaling
pathway connections to the proteins, including NRF2, other
TFs, or first neighbors of NRF2. This option allows mapping
upstream components that could directly or indirectly
influence NRF2 activity. For NRF2, a specific website
function is available, where users can browse regulatory
loops containing possible feedback mechanisms that could
up- or downregulate the expression of NRF2. After or instead
of browsing the website, users can download the NRF2-ome
database as a whole or a user-specified part of it. We provide
a user-friendly download page allowing researchers without
computational background to select and filter the NRF2-ome
database. As the download is possible in CSV and Cytoscape
formats, users without advanced bioinformatics knowledge
can instantly examine and visualize the data of their interest.
As with most bioinformatics resources, the NRF2-ome
has several limitations. Many of the predicted regulatory
loops may not be functional or may function only under very
specific circumstances. Therefore, users should keep in mind
that experimental validation is needed to confirm the func-
tion of a predicted feedback loop. Due to the high complexity
and centrality of NRF2 regulation, it is also possible that in
most cases the effect of one miRNA is negligibly low to the
overall expression of NRF2. As we have limited information
about the effect of most of the transcriptional events (i.e.,
whether the TF has a stimulatory or inhibitory effect), in
most of the cases we cannot distinguish between positive and
negative feedbacks.
Keeping in mind the limitations listed before, the NRF2-
ome is capable to provide both simple predictions (i.e, list
predicted PPIs or regulatory interactions), as well as complex
predictions involving TFs, miRNAs, or signaling pathways.
To illustrate the applicability of NRF2-ome, we presented
examples about MAFG protein containing regulatory loops
and raised the possibility of a connection between NRF2
and the JAK/STAT pathway through STAT1 or STAT3. All
three examples are predictions; thus, further experimental
validation is needed to confirm them. The NRF2-ome can
also be used as an evaluation tool to help researchers explain
a given expression pattern. A combination of the NRF2-
ome network and user-made expression datasets with the
Cytoscape application could help to uncover hidden regula-
tory mechanisms.
NRF2-ome could also be used as a resource for network
pharmacology. The medical importance of NRF2 is coming
from its involvement in oxidative stress, inflammation, and
many age-related diseases, including cancer, neurodegenera-
tive diseases, and diabetes [40, 41]. The NRF2 activators are
potential therapies for oxidative stress, inflammation, and
chemoprevention [40]. Activation of NRF2 in healthy cells
could delay or prevent the onset of some forms of human
cancers [41], but its constitutive activation is responsible for
acquired chemoresistance in tumor cells [42, 43]. Therefore,
investigating the complex interaction and regulatory and
signaling network that influence the activation ofNRF2 could
facilitate novel pharmacological attempts. The NRF2-related
regulatory loops and pathway connections listed in NRF2-
ome could help the evaluation of drug development failures
and guide developers to target proteins with clear effect on
NRF2. We hope that NRF2-ome will serve as resource for
such attempts and help researchers to identify drug targets
that can specifically modify the activity of NRF2.
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4. Conclusions
We have compiled a network resource, which contains a
total of 7,777 manually curated, integrated, and predicted
interaction data of NRF2, its first neighbor interactors, its
target genes, regulating TFs, and miRNAs, as well as sig-
naling pathways regulating NRF2. The user-friendly website
(http://nrf2.elte.hu/) allows researchers without computa-
tional background to search, browse, and download the
database. NRF2-ome contains integrated information on
regulatory loops and pathway connections of NRF2 and
its interactors. NRF2-ome is able to provide interesting
predictions to be tested experimentally as well as to help
researchers to evaluate experimental data or drug treatment
outcomes.
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